Trial intelligence / Profile preview

Norditropin in Children With Growth Failure Associated With IGF Deficiency

NCT00102817Phase 3Completed

Sponsor
Novo Nordisk
Start
May 2003
Primary completion
Dec 2006
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of somatropin in Growth failure (FTT), insulin-like growth factor 1 deficiency, sponsored by Novo Nordisk. Started May 2003; status: completed.

02

Drugs

somatropin
03

Conditions

Growth failure (FTT)insulin-like growth factor 1 deficiency

Beyond the preview

Go deeper on NCT00102817.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00102817.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call